tiprankstipranks
Trending News
More News >
Apogee Therapeutics (APGE)
NASDAQ:APGE
US Market

Apogee Therapeutics (APGE) Cash flow

Compare
337 Followers

Apogee Therapeutics Cash Flow

APGE's free cash flow for Q3 2025 was $-54.26M. For the 2025 fiscal year, APGE's free cash flow was decreased by $-97.40M and operating cash flow was $-54.26M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22
Operating Cash Flow
$ -171.17M$ -74.76M$ -16.43M
Investing Cash Flow
$ -300.46M$ -273.91M$ 0.00
Financing Cash Flow
$ 495.11M$ 315.39M$ 168.32M
End Cash Position
$ 142.08M$ 118.61M$ 151.89M
Free Cash Flow
$ -172.33M$ -74.93M$ -16.43M
Currency in USD

Apogee Therapeutics Cash Flow